Torasemide
From Wikipedia, the free encyclopedia
(Redirected from Torsemide)
| Systematic (IUPAC) name | |
|---|---|
| N-[(isopropylamino)carbonyl]-4-[(3-methylphenyl)amino]pyridine-3-sulfonamide | |
| Identifiers | |
| CAS number | 56211-40-6 |
| ATC code | C03CA04 |
| PubChem | 41781 |
| DrugBank | APRD00217 |
| Chemical data | |
| Formula | C16H20N4O3S |
| Mol. mass | 348.421 g/mol |
| SMILES | eMolecules & PubChem |
| Pharmacokinetic data | |
| Bioavailability | 80-90% |
| Protein binding | Highly bound (>99%). |
| Metabolism | Hepatic (80%) |
| Half life | 3.5 hours; Cirrhosis: 7-8 hours |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
C(US) |
| Legal status | |
| Routes | Oral, IV |
Torasemide (rINN) or torsemide (USAN) is a pyridine-sulfonyl urea type loop diuretic mainly used in the management of edema associated with congestive heart failure. It is also used at low doses for the management of hypertension. It is marketed under the brand name Demadex.
Compared to other loop diuretics, torasemide has a more prolonged diuretic effect than equipotent doses of furosemide and relatively decreased potassium-loss. There is no evidence of torasemide-induced ototoxicity demonstrated in humans [1].
[edit] References
P[;JKIOJ90JOP
[edit] External links
- Medlineplus drug information: Torsemide (Systemic) – information from USP DI Advice for the Patient
|
||||||||||||||||||||||||||||||||||||
| This antihypertensive-related article is a stub. You can help Wikipedia by expanding it. |